€27.10
0.93% today
L&S, Jun 28, 06:34 pm CET
ISIN
US4579852082
Symbol
IART

Integra LifeSciences Holdings Corporation Share price

$28.75
+0.44 1.55% 1M
-15.13 34.48% 6M
-14.80 33.98% YTD
-12.25 29.88% 1Y
-39.77 58.04% 3Y
-25.62 47.12% 5Y
+7.44 34.92% 10Y
Nasdaq, Closing price Thu, Jun 27 2024
ISIN
US4579852082
Symbol
IART
Sector

Key figures

Market capitalization $2.27b
Enterprise Value $3.64b
PER (TTM) P/E ratio 56.72
EV/FCF (TTM) EV/FCF 59.82
EV/Sales (TTM) EV/Sales 2.38
P/S ratio (TTM) P/S ratio 1.48
P/B ratio (TTM) P/B ratio 1.42
Sales growth (TTM) Sales growth -2.07%
Turnover (TTM) Turnover $1.53b
EBIT (operating result TTM) EBIT $134.13m
Free cash flow (TTM) Free cash flow $60.93m
Cash position $663.10m
EPS (TTM) EPS $0.51
P/E ratio expected 25.59
P/S ratio expected 1.36
EV/Sales expected 2.18
Short interest 5.86%
Show more

Is Integra LifeSciences Holdings Corporation a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Integra LifeSciences Holdings Corporation Share analysis

Unlock scores for free

Analyst opinions

14 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:

3x Buy
21%
8x Hold
57%
3x Sell
21%

Analyst opinions

14 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:

Buy
21%
Hold
57%
Sell
21%

Financial data from Integra LifeSciences Holdings Corporation

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
1,530 1,530
2% 2%
100%
- Direct costs 657 657
5% 5%
43%
872 872
7% 7%
57%
- Selling and administrative expenses 525 525
13% 13%
34%
- Research and development costs 90 90
16% 16%
6%
257 257
34% 34%
17%
- Depreciation and amortization 123 123
1% 1%
8%
EBIT (operating result) EBIT 134 134
50% 50%
9%
Net profit 40 40
77% 77%
3%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Integra LifeSciences Holdings Corporation share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Integra LifeSciences Holdings Corporation Share News

Neutral
GlobeNewsWire
about 2 months ago
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET.
Neutral
Seeking Alpha
about 2 months ago
Integra LifeSciences Holdings Corporation [IART] Q1 2024 Earnings Conference Call May 6, 2024 8:30 AM ET Company Participants Jan De Witte - President & CEO Lea Knight - CFO Chris Ward - IR Conference Call Participants Vik Chopra - Wells Fargo Steve Lichtman - Oppenheimer Kristen Stewart - C.L. King & Associates Robbie Marcus - J.P.
Neutral
GlobeNewsWire
about 2 months ago
PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024.
More Integra LifeSciences Holdings Corporation News

Company profile

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Head office United States
CEO Jan Witte
Employees 5,329
Founded 1989
Website www.integralife.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now